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Introduction 69
Unlike animals, plants do not possess a circulatory adaptive immune system. Instead, they rely on an 70 efficient cellular innate immunity system to defend against various pathogens. The first layer of this 71 immunity system is initiated by perception of pathogen-or microbe-associated molecular patterns 72 (PAMPs/MAMPs) by pattern recognition receptors. A well-studied system is the recognition of the 73 This signaling network induces transcriptional and metabolic reprogramming to establish pattern-80 triggered immunity (PTI). A second layer of immunity is the so-called effector-triggered immunity (ETI) 81 that is activated after direct or indirect recognition of pathogen effectors or their modifications of host 82 proteins, respectively. However, a distinction between PTI and ETI is not always clear (Thomma et al., 83 2011). 84
In Arabidopsis thaliana, the best studied stress-responsive MAPKs are MPK3, MPK4, and MPK6, 85
which are known to be activated during pathogen infection or elicitation with PAMPs, such as flg22 and In this work, we investigated CAMTA3 phosphorylation and how this affects its function. We show that 154 CAMTA3 is indeed phosphorylated by flg22-responsive MAPKs, which promotes its destabilization. 155
We could not confirm physical interaction between CAMTA3 and SR1IP1 but show that they have 156 distinct cellular localization and therefore cannot physically interact prior to PTI activation. Finally, we 157 also uncovered that there are additional flg22-responsive kinases that phosphorylate CAMTA3, which 158 may be a CDPK or another kinase downstream of CDPK. 159
160

Results
161
CAMTA3 negatively regulates defense-related gene expression 162
Datamining of expression databases (Hruz et al., 2008) indicated that besides salicylic acid, treatment 163 with PAMPs (e.g. flg22, elf26 or chitin) induces the accumulation of CAMTA3 transcripts. By RT-164 qPCR, we confirmed the increase in CAMTA3 expression in Arabidopsis thaliana Col-0 seedlings 165 stimulated with flg22 ( Fig. 1A ). CAMTA3 mRNA levels increased rapidly within 30-60 min of flg22 166 treatment and subsided to near basal levels after ~4 h. Since CAMTA3 is a transcription factor, this 167 increased expression may contribute to the flg22-induced transcriptional response. CAMTA3 is known 168 to regulate expression positively, such as for the cold-responsive gene, CBF2 ( the effect of CAMTA3 on PAMP-regulated gene expression, CAMTA3 overexpression (OE) lines were 172 generated. The enhanced basal expression (i.e. in the mock treated tissues) of CAMTA3 in two 173 independent OE lines was confirmed by RT-qPCR. Flg22 treatment further raised CAMTA3 expression 174 in the OE lines ( Fig. 1B) , which is presumably the sum of expression arising from the transgene and the 175 inducible expression of the endogenous gene. Next, we analyzed the effect of CAMTA3 on expression 176 of EDS1. As expected, camta3 mutants show high basal EDS1 transcript levels and CAMTA3 177 overexpression reduced EDS1 transcript accumulation. Flg22-induced EDS1 expression was enhanced 178 in the camta3 mutants and reciprocally, it was reduced in the two independent OE lines (Fig. 1C) . A 179 similar effect was also shown on NHL10 (Fig. 1D ), which has not been reported as a direct CAMTA3 180 target but includes a potential CAMTA3-binding site in its promoter. These observations are consistent 181 with CAMTA3 functioning as a negative regulator (repressor) during plant immunity response. The 182 PAMP-induced early expression of CAMTA3 may thus potentially serve to shut down expression of 183 downstream target genes. 184
flg22 induces CAMTA3 phosphorylation and destabilization in vivo 186
To investigate the effect of flg22 treatment on the CAMTA3 protein levels, western blot analysis was 187 performed with protein extracted from Arabidopsis protoplasts that transiently express HA-epitope- By contrast, cold stress (transfer to ice-cold media and placed into a 4°C cold room) did not induce any 213 CAMTA3 degradation within the tested time period and in fact, there appeared to be enhanced protein 214 stability (or less protein degradation) despite termination of protein translation by CHX treatment (Fig.  215 2C). This is in line with CAMTA3 functioning as a transcriptional activator for cold stress ( trigger CAMTA3 phosphorylation and degradation, suggesting differential mechanism exists to 220 determine positive or negative functions of CAMTA3 in these distinct stress context. 221
222
CAMTA3 interacts with and is phosphorylated by PAMP-responsive MAPKs 223
MAPKs are rapidly activated after flg22 treatment and are thus candidate kinases responsible for the 224 His-tagged CAMTA3 and GST-tagged MPK3, MPK4 or MPK6. While nearly similar levels of in vitro 231 autophosphorylation of the kinases were seen, CAMTA3 was phosphorylated by MPK3 and MPK6, but 232 barely by MPK4 ( Fig 3B) . on the protein levels were then monitored by Phos-Tag or standard western blot, respectively. CAMTA3 238 was phospho-shifted when co-expressed with CA-MPK6 and accumulated to lower levels. For CA-239 MPK3 co-expression, some phosphorylation (but weaker compared to MPK6) was observed but a strong 240 CAMTA3 destabilization was seen. Consistent with in vitro kinase assay, CA-MPK4 co-expression did 241 not induce CAMTA3 phospho-shift ( Fig. 3C ). Thus, MPK4 is probably not involved in inducing in vivo 242 phosphorylation and destabilization of CAMTA3. However, some caveats to the above interpretations 243 include: (1) the CA-MPK4 displayed lower autophosphorylation activity than the other two kinases; (2) 244 it cannot be excluded that substrate specificities or activities of these mutated MAPKs are comparable 245 to the MAPKs natively activated through upstream MAPK kinases. 246
To validate our results, we transiently expressed in protoplasts a constitutively active MKK5 (MKK5 DD ) 247 to specifically activate endogenous MPK3 and MPK6 but not MPK4 (Lee et al., 2004; Lassowskat et 248 al., 2014). In this case, MPK3/6 are activated "naturally" through phosphorylation of its kinase 249 activation loop and not through mutation. Similar to observations above for CA-MPK3 and CA-MPK6, 250 CAMTA3 protein level was reduced through MKK5 DD co-expression. The phosphorylated CAMTA3 251 proteins are difficult to visualize in the Phos-Tag gels since the strongly reduced protein levels are 252 further separated into smeary, barely detectable, bands. However, the slower mobility of these fuzzy 253 bands is in agreement with MPK3/6-mediated phosphorylation. Control transfection without any MKKs 254 or co-transfection with a kinase-inactive MKK5 (MKK5 KR ) did not show these effects (Fig. 3D ). Hence, 255
the results above suggest that two out of three known flg22-responsive MAPKs phosphorylate 256 CAMTA3, and in vivo flg22-induced CAMTA3 destabilization may be triggered by phosphorylation 257 via MPK3 and MPK6. 258 259 CAMTA3 is phosphorylated by PAMP-responsive MPK3/6 at multiple sites, which contribute to 260
CAMTA3 protein destabilization 261
After confirming in vitro and in vivo CAMTA3 phosphorylation by MPK3 and MPK6, we proceeded to 262 determine the phospho-sites in CAMTA3. CAMTA3 contains 11 potential MAPKs phosphorylation 263 sites, which are serine or threonine followed by a proline (S/TP) ( Fig. 4A ). Both in vitro kinase assay 264 (with non-radioactive ATP) and infiltrating flg22 to CAMTA3-overexpression lines were used for 265 collecting phosphorylated CAMTA3 protein samples. MPK3-or MPK6-phosphorylated CAMTA3 266 bands, or flg22-induced phosphorylated CAMTA3 proteins immunoprecipitated from overexpression 267 plant extracts, were excised after SDS-PAGE separation. After tryptic digestion and phospho-peptide 268 enrichment, samples were subjected to mass spectrometry (MS) analysis (MS2 spectra mapping the 269 respective phospho-sites are shown in Fig. S1 ). Three phospho-peptides with phosphorylated S272, 270 S454, or S780 were detected ( . Based on these data, we generated phospho-mutants: CAMTA3-274 mutP1 and -mutP2, with respectively three or five sites mutated to non-phosphorylatable residues ( Fig.  275 4A). However, in vitro MPK3-or MPK6-mediated phosphorylation of the CAMTA3-mutP1 and -mutP2 276 variants was not reduced compared to CAMTA3-WT ( Fig. 4B ), suggesting the presence of additional 277
MAPK-targeted sites. 278
To increase MS sequence coverage of CAMTA3 we repeated the experiment but digested the protein 279 with both trypsin and endoproteinase Glu-C prior to MS analysis. This resulted in more than 60% 280 sequence coverage that encompass most of the SP/TP motifs, leading to the identification of 281 phosphorylation at T243, S587 and S780 ( Fig. S1 ). Notably, T243 ( Fig. 4A , marked in green) is a novel 282 phospho-site, never detected in any previous reports. When the phospho-mutant CAMTA3-mutP2+ 283 (containing phospho-site mutations at S8, T243, S272, S454, S587 and S780) was tested, in vitro MPK3-284 or MPK6-mediated phosphorylation was strongly reduced compared to CAMTA3-WT ( Fig. 4B ), so that 285 these six sites are likely the major MPK3/6-targeted sites. We also generated CAMTA3-mutP3 (as a 286 phospho-null for all 11 potential phospho-sites) and the corresponding phospho-mimetic mutant 287 (CAMTA3-mimic), in which all 11 potential sites (S/T) were substituted by aspartic acids (D) (Fig. 4A) . 288
Phosphorylation of these variants was completely lost (Fig. 4B ), which also proved that MPK3/6 did 289 not unspecifically phosphorylate other residues in CAMTA3. 290
To investigate the role of phosphorylation in protein destabilization, we compare the stability of the 291 different CAMTA3 phosphosite variants. Co-expression of MKK5 DD (or the kinase-inactive MKK5 KR 292 variant as a control) was employed to investigate the actions of MPK3/6. A quantitative western blot 293 system (Li-COR Odyssey® CLx multiplex imaging system) was used to determine the protein levels in 294 five replicates (consisting of independent protoplast samples). differences in protein stability may be partially masked. However, note that basal expression of all the 300 phospho-site mutants are higher levels than the CAMTA3-WT while the opposite is true for the 301 CAMTA3-mimic ( Fig 4D) . Thus, the MAPK-targeted phospho-sites may be crucial for maintaining 302 protein stability. 303
As seen in the representative western blot (Fig. 4C) , the mutP2+ and mutP3 phospho-mutants appear 304 slightly more stable than the CAMTA3-WT protein after MPK3/6 activation, which is substantiated by 305 statistical analysis for the mutP3 variant. Although interpretation for mutP2+ lacked statistical 306 robustness, this may be a type II (false negative) statistical error because we do see this qualitative 307 difference in most of the independent replicates. As seen in the recalculation of the percent decrease 308 The potential mechanism behind CAMTA3 destabilization through phosphorylation is still unknown. A 313 previous study proposed that the CAMTA3-interacting SR1IP1 recruits CAMTA3 for ubiquitination and degradation by the 26S proteasome (Zhang et al., 2014). To test the involvement of SR1IP1, we 315 aimed to check if phosphorylation affected SR1IP1-CAMTA3 interaction. We performed several assays 316 including yeast two-hybrid, bimolecular fluorescence complementation (BiFC) and split-assays in 317 transfected Arabidopsis protoplasts ( Fig. S2 ), but none of the assays supported interaction between 318 SR1IP1 and CAMTA3. 319 320
MAPK-induced phosphorylation triggers CAMTA3 subcellular relocalization 321
To clarify the discrepancy to the literature, we looked at the cellular distribution of the two proteins. 322
CAMTA3 is a transcription factor and mainly localized in the nucleus (Yang and Poovaiah, 2002), 323 which we could also confirm in unstressed protoplasts using a CAMTA3-YFP fusion construct ( Fig.  324 5A, upper panel). However, SR1IP1-CFP signals are in the periphery (presumably plasma membrane) 325 of the protoplasts (Fig. 5A, lower panel) . Hence, the different localization might explain why we could 326 not detect any interaction between SR1IP1 and CAMTA3 in any of the plant cell-based assays. For yeast 327 two-hybrid assay, we employed a GAL4-based system while the reported SR1IP1-CAMTA3 interaction 328 is based on the pSOS system (Zhang et al., 2014), which relies on myristylation of the bait proteins. 329
Thus, the recruitment of the reporter to the plasma membrane may permit interaction. Nevertheless, the 330 distinct localization of CAMTA3 and SR1IP1 suggests that they cannot physically interact unless there 331 is a re-localization of either proteins from the nucleus or the plasma membrane, respectively. 332
Interestingly, the CAMTA3-YFP signal relocated from nucleus to the cytoplasm after flg22 elicitation, 333 and multiple cytoplasmic aggregates were often observed ( Fig. 5B ; see additionally the time course 334 experiment in Fig S3A) . The aggregates are not cleaved YFP fragments since western blot analysis 335 revealed intact CAMTA3-YFP protein bands (Fig. S3B) . By contrast, SR1IP1 localization was not 336 visibly affected by flg22 treatment. Although the CAMTA3 relocalization into the cytoplasm may 337 potentially allow interaction with SR1IP1 and indeed, there seems to be partial co-localization between 338 CAMTA3-YFP and SR1IP1-CFP after flg22 treatment (Fig. 5B) , we never obtain any BiFC or split-339 LUC signals between CAMTA3 and SR1IP1 even upon flg22 elicitation (Fig. S2 ). Nonetheless, we 340 cannot exclude that CAMTA3-SR1IP1 does interact upon flg22 elicitation but is degraded too rapidly 341 for detection of the complex. 342
Notably, activation of MPK3/6 (through MKK5 DD co-expression) also induced the CAMTA3 343 relocalization to the cytoplasm (Fig. 5B, left lower panels) , thus phenocopying the effects of flg22 344 elicitation. The non-phosphorylatable CAMTA3-mutP3 remained nuclear-localized with the MKK5 DD 345 co-expression ( Fig. 5B, right lower panels) , demonstrating that the mutated phospho-sites are crucial for 346 the relocalization and that CAMTA3 nuclear export can be triggered by its MPK3/6-mediated 347 phosphorylation. On the other hand, these phospho-sites also appear to be irrelevant for the flg22 348 response since the CAMTA3-mutP3 mutant still re-localized to the cytoplasm upon flg22 treatment ( During the Phos-Tag-based analysis of CAMTA3 phospho-status, we noticed that flg22 treatment can 356 induce additional mobility shift to the phosphoshift already triggered by MKK5 DD co-expression (i.e. in 357 vivo MPK3/6 activation) ( Fig. 6A, left panel) . This strong mobility shift was also seen for the mutP3 358 variant, which showed no difference in the mobility shift between co-expressing MKK5 KR and MKK5 DD 359 were transiently co-expressed with CAMTA3 in the protoplasts, most of them induce a phospho-shift 370 of CAMTA3 and, in part, a change in CAMTA3 protein levels (Fig. 6B ). According to the quantitative 371 western blot and statistical analysis, CAMTA3 protein stability was significantly reduced by co-372 expression of CPK1, CPK2, or CPK5, while the tested members from subfamily III and IV did not 373 reduce but increased CAMTA3 levels significantly (Fig. 6B, lower Thus, we tested the role of CPK5 by transiently expressing CAMTA3-WT (or mutP3) together with 381 CPK5-VK or a kinase-deficient version (CPK5m-VK) into protoplasts. CPK5-VK expression led to a 382 strong destabilization of CAMTA3. Extended exposure of the western blots was necessary to visualize 383 the low levels of CAMTA3-WT or mutP3. Importantly, the strong phospho-shift of CAMTA3 induced by CPK5-VK is comparable to the shift induced by flg22 stimulation (Fig. 6C ). Since this phospho-shift 385 can be seen in both WT and mutP3 versions of CAMTA3, there is phosphorylation at non-MAPK 386 targeted sites through CPK5-VK. This further supports CPK5 as the unknown flg22-responsive 387 kinase(s) that could target CAMTA3. 388
389
CAMTA3 is not a direct target of CPK5 390
To investigate whether CAMTA3 may be a target for CPK5, CAMTA3 interaction with CPK5 was 391 tested. BiFC assay performed in protoplasts showed reconstituted YFP fluorescence, suggesting that 392
CAMTA3 can indeed interact directly with full length CPK5. A kinase-deficient version CPK5m was 393
shown to interact with CAMTA3 as well ( Fig. 7A, upper panel) , which indicates that the interaction 394 between CAMTA3 and CPK5 is not dependent on its kinase activity. BiFC signals co-localized with a 395 presented here support the latter, i.e. CAMTA3 is a negative regulator of defence genes, where 413 CAMTA3 (overexpression) suppresses both the basal and flg22-induced expression of defence genes 414 ( Fig 1C,D) . Furthermore, upon flg22 perception, activated MPK3 and MPK6 can phosphorylate 415 CAMTA3 directly, which promotes CAMTA3 degradation via a proteasome-dependent pathway and 416 also the relocalization of CAMTA3 from the nucleus to cytoplasm. These two processes can thus lead 417 to de-repression of downstream target genes. The transcriptional upregulation of CAMTA3 by flg22 may thus represent a negative feedback mechanism to replace the degraded CAMTA3 proteins and shut down 419 defence gene expression. 420
Besides MAPKs, additional flg22-responsive kinase(s) can induce CAMTA3 phosphorylation that 421 strongly promotes its degradation. This is most likely an unknown kinase downstream of CPK5; 422 although we cannot exclude that CPK5 can directly phosphorylate CAMTA3 under optimal conditions 423 (such as the presence of additional co-factors). Taken together, our findings suggest that CAMTA3 may Since CAMTA3 physically interacted in vivo with CPK5 in the nucleus, both may be needed to identify 447 the required associated component(s). Alternatively, some form of CAMTA3 post-translational 448 modifications may be required before direct phosphorylation by CPK5. However, this is unlikely to be 449 through MAPK phosphorylation since CPK5 or flg22 treatment can both still induce a phospho-shift of 450 the CAMTA3-P3 mutant (where all 11 potential MAPK phosphorylation sites are mutated). 451
In agreement to pathogen-induced CAMTA3 degradation, we show that flg22-induced CAMTA3 452 phosphorylation leads to its in vivo destabilization and propose this may de-repress expression of 453 downstream target genes. Equally possible would be a direct phospho-dependent reduction in DNA 454 binding properties of CAMTA3. If phosphorylation is involved, only allosteric effects can be expected 455 since the key MAPK-targeted phosphosites are not within the DNA-binding domain (see Fig. 4A ). 456
Unfortunately, we were unable to obtain convincing EMSA (electrophoretic mobility shift assay) data 457 proving specific CAMTA3 binding to "CGCG"-core containing DNA probes ( Fig S4) . In conclusion, the isolation of CAMTA3 mutants in numerous independent genetic screens for 512 pathogen/stress responses coupled with its post-translational control through (direct/indirect) 513 phosphorylation by two major stress-responsive kinase pathways, namely MAPKs and CDPKs, 514 highlights it as a node in abiotic and biotic stress signalling network. The convergence between 515 environmental (cold) and pathogen (or other biotic stresses) signalling on CAMTA3 suggests it may 516 control the interplay and trade-offs between growth and stress response. There are still many gaps in the 517 understanding of how CAMTA3 navigates these different roles but multiple phosphorylation and 518 nucleo-cytoplasmic trafficking may be involved. 519 520 Acknowledgements 521
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Real-time PCR analysis 555
Total RNA was extracted from plant tissues using TRIzol reagent (Roth). 2 µg of RNA was used for 556 cDNA synthesis (Thermo Fisher Scientific). Diluted cDNA (1:10) was used for real-time PCR following 557 the manufacturer's protocol from 5×QPCR Mix EvaGreen® (ROX) (Bio & Sell). Primers and probes 558 are listed in Table S3 . The PCR was performed in MX3005P cyclers (Agilent), and the program 559 
Quantitative Western blot
In vitro kinase assay 621
In vitro phosphorylation assay of CAMTA3 by MAPKs was performed in kinase substrate buffer 1 (20 622 mM HEPES pH 7.5; 15 mM MgCl2; 5 mM EGTA; 1 mM DTT; Protease-Inhibitor Mix HP; 2 µCi 623 [gamma-32 P]ATP) using recombinant His-CAMTA3 variants and GST-MPK3, 4 and 6. Samples were 624 incubated for 30 min at 30°C, and the reactions were stopped by adding 5× loading buffer and 5 min 625 boiling. Samples were subsequently separated on SDS-PAGE, stained with CBB and analyzed by 626 autoradiography. Similarly, in vitro phosphorylation assay of CAMTA3 by strepII-CPK5-FL or His-627 tagged CPK5-VK was performed as above except that EGTA was excluded and replaced with 0.5 µg 628
Calmodulin/0.1 mM CaCl2. Reciprocally, to check for calcium dependency (negative control), CaCl2 629 was replaced with 2.4 mM EGTA. 630 631 Phosphorylation site mapping 632 threonine as variable modifications. The precursor tolerance was set to 7 ppm and the product ion mass 656 tolerance was set to 0.8 Da. A decoy database search was performed to determine the peptide spectral 657 match (PSM) and peptide identification false discovery rates (FDR). Phosphorylated peptides with a 658 score surpassing the false discovery rate threshold of 0.01 (q-value<0.01) were considered positive 659 identifications. The phosphoRS module was used to specifically map phosphorylation to amino acid 660 residues within the primary structure of phosphopeptides. Figure S1 MS2 spectra of peptides with phosphorylated site found in CAMTA3. 690 Figure S2 Yeast-or plant-based interaction assays between CAMTA3 and SR1IP1. 691 Figure S3 Flg22 treatment induces subcellular re-localization of CAMTA3. 692 Figure S4 EMSA for in vitro binding of full-length CAMTA3 to a "CGCG-containing" promoter 693 fragment of EDS1. 694 Figure S5 CAMTA3 is not phosphorylated by CPK5 in vitro. 695 Figure S6 Compilation of western blots validating the expression of intact fusion proteins for the BiFC 696 or co-localization experiments. 697 698 699 Table S1 : Primers for cloning into entry vector pENTR/D 700 Table S2 : Primers used for site-directed mutagenesis of CAMTA3 in entry vectors 701 Table S3 : Primers and probes for RT-qPCR 702 Table S4 : 
930
Western blot detection of intact proteins is shown in Fig. S6B . 
933
A. Additional kinases are involved in flg22-induced phosphorylation of CAMTA3. Arabidopsis protoplasts were transfected 934 to co-express CAMTA3-WT (or CAMTA3-mutP3) with constitutively active MKK5 DD or its kinase-dead variant (KR), 935 respectively. One batch of the protoplasts transfected with MKK5 DD was additionally treated with 100 nM flg22 for 10 min. 
